Hsbc Holdings PLC Sells 28,679 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Hsbc Holdings PLC cut its position in HCA Healthcare, Inc. (NYSE:HCA) by 7.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 382,339 shares of the company’s stock after selling 28,679 shares during the quarter. Hsbc Holdings PLC owned 0.15% of HCA Healthcare worth $123,245,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of HCA. Bangor Savings Bank raised its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its position in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. bought a new position in shares of HCA Healthcare during the first quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 over the last ninety days. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $399.89 on Thursday. The business’s fifty day simple moving average is $367.24 and its 200 day simple moving average is $339.56. The firm has a market capitalization of $104.74 billion, a P/E ratio of 19.93, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $404.90. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company posted $4.29 earnings per share. As a group, analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.66%. HCA Healthcare’s payout ratio is presently 13.16%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on HCA. Robert W. Baird began coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Wells Fargo & Company raised their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Monday, August 19th. Finally, Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.